Visterra
Visterra develops and commercializes antibody therapeutics for the treatment of pandemic influenza and chronic kidney diseases.
Business Model:
Revenue: $4.5M
Employees: 51-200
Industries / Tags:
Detailed Visterra Information
Visterra was acquired by
Otsuka Pharmaceutical.
The acquisition happend on 2018-07-11.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 275 2nd Avenue
City: Waltham
State: MA
Zip: 02451
Country: US
Financial Info
Stage:
series c
Raised Last:
$24M
Raised Total:$125M
Social
Metrics
8,118,829Website Global Rank
380Website Monthly Traffic
Twitter Followers
Description
Visterra develops and commercializes antibody therapeutics for the treatment of pandemic influenza and chronic kidney diseases.
Contact Phone:
+16174981070
Contact Email:
Visterra went public on the NASDAQ
Listed Exchange:
NASDAQ
Ticker Symbol:
VIST
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
